ID29514A - 2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT - Google Patents

2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT

Info

Publication number: ID29514A
Authority: ID; Indonesia
Prior art keywords: heteroaril; aril; imidazo; compositions; substituted pyrimidine
Prior art date: 1999-11-10

Application number

IDW00200101720A

Other languages

English (en)

Inventor

John H Dodd

James R Henry

Kenneth C Rupert

Original Assignee

Ortho Mcneil Pharmacetical Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1999-11-10

Filing date

2000-10-27

Publication date

2001-09-06

2000-10-27 Application filed by Ortho Mcneil Pharmacetical Inc filed Critical Ortho Mcneil Pharmacetical Inc

2001-09-06 Publication of ID29514A publication Critical patent/ID29514A/id

Links

CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical class C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/02—Stomatological preparations, e.g. drugs for caries, aphtae, periodontitis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/18—Drugs for disorders of the alimentary tract or the digestive system for pancreatic disorders, e.g. pancreatic enzymes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Organic Chemistry (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Rheumatology (AREA)
Physical Education & Sports Medicine (AREA)
Biomedical Technology (AREA)
Communicable Diseases (AREA)
Orthopedic Medicine & Surgery (AREA)
Oncology (AREA)
Virology (AREA)
Neurosurgery (AREA)
Diabetes (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Dermatology (AREA)
Pain & Pain Management (AREA)
Cardiology (AREA)
Pulmonology (AREA)
Obesity (AREA)
Urology & Nephrology (AREA)
Endocrinology (AREA)
Hospice & Palliative Care (AREA)
Emergency Medicine (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Hematology (AREA)
Molecular Biology (AREA)

IDW00200101720A 1999-11-10 2000-10-27 2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT ID29514A (id)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US16470099P	1999-11-10	1999-11-10

Publications (1)

Publication Number	Publication Date
ID29514A true ID29514A (id)	2001-09-06

Family

ID=22595694

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IDW00200101720A ID29514A (id)	1999-11-10	2000-10-27	2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT

Country Status (27)

Country	Link
US (1)	US6610697B1 (id)
EP (1)	EP1140939B1 (id)
JP (1)	JP2003513977A (id)
KR (1)	KR20010089805A (id)
CN (1)	CN1255406C (id)
AR (1)	AR026410A1 (id)
AT (1)	ATE288915T1 (id)
AU (1)	AU784484B2 (id)
BG (1)	BG65106B1 (id)
BR (1)	BR0007447A (id)
CA (1)	CA2361139A1 (id)
CZ (1)	CZ20012494A3 (id)
DE (1)	DE60018037T2 (id)
ES (1)	ES2237470T3 (id)
HK (1)	HK1043591B (id)
HU (1)	HUP0200207A3 (id)
ID (1)	ID29514A (id)
IL (1)	IL144238A (id)
MX (1)	MXPA01007019A (id)
NO (1)	NO320422B1 (id)
NZ (1)	NZ512957A (id)
PL (1)	PL348924A1 (id)
PT (1)	PT1140939E (id)
RU (1)	RU2264403C2 (id)
SK (1)	SK9892001A3 (id)
UA (1)	UA70350C2 (id)
WO (1)	WO2001034605A1 (id)

Families Citing this family (61)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
PE20020506A1 (es)	2000-08-22	2002-07-09	Glaxo Group Ltd	Derivados de pirazol fusionados como inhibidores de la proteina cinasa
US6670357B2 (en)	2000-11-17	2003-12-30	Bristol-Myers Squibb Company	Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors
US6867300B2 (en)	2000-11-17	2005-03-15	Bristol-Myers Squibb Company	Methods for the preparation of pyrrolotriazine compounds useful as kinase inhibitors
US7196095B2 (en) *	2001-06-25	2007-03-27	Merck & Co., Inc.	(Pyrimidinyl) (phenyl) substituted fused heteroaryl p38 inhibiting and PKG kinase inhibiting compounds
GB0124941D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124938D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124934D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124933D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124936D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124931D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
GB0124939D0 (en)	2001-10-17	2001-12-05	Glaxo Group Ltd	Chemical compounds
US6921762B2 (en)	2001-11-16	2005-07-26	Amgen Inc.	Substituted indolizine-like compounds and methods of use
DE60210819T2 (de)	2001-12-17	2007-04-19	Smithkline Beecham Corp.	Pyrazolopyridazinderivate
JP4472349B2 (ja)	2002-02-12	2010-06-02	スミスクラインビーチャムコーポレーション	ｐ３８阻害薬として有用なニコチンアミド誘導体
US7388009B2 (en)	2002-04-23	2008-06-17	Bristol-Myers Squibb Company	Heteroaryl-substituted pyrrolo-triazine compounds useful as kinase inhibitors
BR0309669A (pt)	2002-04-23	2005-03-01	Bristol Myers Squibb Co	Compostos de anilina de pirrolo-triazina úteis como inibidores de cinase
WO2003091229A1 (en)	2002-04-23	2003-11-06	Bristol-Myers Squibb Company	Aryl ketone pyrrolo-triazine compounds useful as kinase inhibitors
TW200400034A (en)	2002-05-20	2004-01-01	Bristol Myers Squibb Co	Pyrazolo-pyrimidine aniline compounds useful as kinase inhibitors
ES2278170T3 (es)	2002-07-09	2007-08-01	BOEHRINGER INGELHEIM PHARMA GMBH & CO.KG	Composiciones farmaceuticas de anticolinergicos e inhibidores de la quinasa p38 en el tratamiento de enfermedades respiratorias.
WO2004052315A2 (en)	2002-12-11	2004-06-24	Merck & Co., Inc.	Tyrosine kinase inhibitors
GB0308186D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0308201D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
GB0308185D0 (en)	2003-04-09	2003-05-14	Smithkline Beecham Corp	Novel compounds
ATE439837T1 (de)	2003-06-03	2009-09-15	Novartis Ag	5-gliedrige heterocyclische p-38 inhibitoren
HRP20110757T1 (hr)	2003-06-26	2011-11-30	Novartis Ag	Inhibitori kinaze p38 bazirani na 5-članom heterociklu
MXPA06000915A (es)	2003-07-25	2006-03-30	Novartis Ag	Inhibidores de quinasa p-38.
GB0318814D0 (en)	2003-08-11	2003-09-10	Smithkline Beecham Corp	Novel compounds
US7419978B2 (en)	2003-10-22	2008-09-02	Bristol-Myers Squibb Company	Phenyl-aniline substituted bicyclic compounds useful as kinase inhibitors
NZ548396A (en) *	2004-01-31	2010-06-25	Actimis Pharmaceuticals Inc	Imidazo[1,2-C]pyrimidinylacetic acid derivatives
US20050288502A1 (en) *	2004-06-25	2005-12-29	Andersen Denise L	Substituted heterocyclic compounds and methods of use
US7504521B2 (en)	2004-08-05	2009-03-17	Bristol-Myers Squibb Co.	Methods for the preparation of pyrrolotriazine compounds
US20060035893A1 (en)	2004-08-07	2006-02-16	Boehringer Ingelheim International Gmbh	Pharmaceutical compositions for treatment of respiratory and gastrointestinal disorders
US7148348B2 (en)	2004-08-12	2006-12-12	Bristol-Myers Squibb Company	Process for preparing pyrrolotriazine aniline compounds useful as kinase inhibitors
AU2005278292B2 (en) *	2004-08-31	2011-09-08	Msd K.K.	Novel substituted imidazole derivatives
PE20060777A1 (es)	2004-12-24	2006-10-06	Boehringer Ingelheim Int	Derivados de indolinona para el tratamiento o la prevencion de enfermedades fibroticas
CA2594325A1 (en) *	2004-12-28	2006-07-06	Takeda Pharmaceutical Company Limited	Condensed imidazole compound and use thereof
US20060178388A1 (en)	2005-02-04	2006-08-10	Wrobleski Stephen T	Phenyl-substituted pyrimidine compounds useful as kinase inhibitors
US7473784B2 (en)	2005-08-01	2009-01-06	Bristol-Myers Squibb Company	Benzothiazole and azabenzothiazole compounds useful as kinase inhibitors
US7709468B2 (en)	2005-09-02	2010-05-04	Abbott Laboratories	Imidazo based heterocycles
AU2007223342A1 (en)	2006-03-07	2007-09-13	Bristol-Myers Squibb Company	Pyrrolotriazine aniline prodrug compounds useful as kinase inhibitors
US7683060B2 (en)	2006-08-07	2010-03-23	Incyte Corporation	Triazolotriazines as kinase inhibitors
WO2008057775A2 (en)	2006-10-27	2008-05-15	Bristol-Myers Squibb Company	Heterocyclic amide compounds useful as kinase inhibitors
KR101532256B1 (ko)	2006-11-22	2015-06-29	인사이트 코포레이션	키나제 억제제로서의 이미다조트리아진 및 이미다조피리미딘
US7943617B2 (en)	2006-11-27	2011-05-17	Bristol-Myers Squibb Company	Heterobicyclic compounds useful as kinase inhibitors
US7977336B2 (en) *	2006-12-28	2011-07-12	Banyu Pharmaceutical Co. Ltd	Aminopyrimidine derivatives as PLK1 inhibitors
WO2008133192A1 (ja) *	2007-04-19	2008-11-06	Takeda Pharmaceutical Company Limited	縮合イミダゾール化合物およびその用途
EP1992344A1 (en)	2007-05-18	2008-11-19	Institut Curie	P38 alpha as a therapeutic target in pathologies linked to FGFR3 mutation
KR101002490B1 (ko) *	2007-06-09	2010-12-17	동아제약주식회사	유데나필을 유효성분으로 함유하는 만성 심부전증 치료용약학적 조성물
WO2009143211A2 (en)	2008-05-21	2009-11-26	Incyte Corporation	Salts of 2-fluoro-n-methyl-4-[7-(quinolin-6-yl-methyl)- imidazo[1,2-b][1,2,4]triazin-2-yl]benzamide and processes related to preparing the same
EP2307411B1 (en)	2008-06-20	2014-01-01	Bristol-Myers Squibb Company	Triazolopyridine compounds useful as kinase inhibitors
US8338604B2 (en)	2008-06-20	2012-12-25	Bristol-Myers Squibb Company	Imidazopyridine and imidazopyrazine compounds useful as kinase inhibitors
HRP20150345T1 (hr) *	2009-09-24	2015-05-08	F. Hoffmann-La Roche Ag	Derivati imidazopiridina ili imidazopirimidina kao inhibitori fosfodiesteraze 10a
EA025304B1 (ru)	2010-02-03	2016-12-30	Инсайт Холдингс Корпорейшн	ИМИДАЗО[1,2-b][1,2,4]ТРИАЗИНЫ В КАЧЕСТВЕ c-Met ИНГИБИТОРОВ
US8410117B2 (en) *	2010-03-26	2013-04-02	Hoffmann-La Roche Inc.	Imidazopyrimidine derivatives
WO2012031057A1 (en)	2010-09-01	2012-03-08	Bristol-Myers Squibb Company	Bms- 582949 for the treatment of resistant rheumatic disease
ES2629389T3 (es) *	2013-05-23	2017-08-09	H. Hoffnabb-La Roche Ag	2-fenilimidazo[1,2-a]pirimidinas como agentes de obtención de imágenes
GB201321736D0 (en) *	2013-12-09	2014-01-22	Ucb Pharma Sa	Therapeutic agents
WO2016081364A1 (en) *	2014-11-21	2016-05-26	Rigel Pharmaceuticals, Inc.	Fused imidazole derivatives as tgf-beta inhibitors
US20190060286A1 (en)	2016-02-29	2019-02-28	University Of Florida Research Foundation, Incorpo	Chemotherapeutic Methods
CN111936136B (zh) *	2017-11-14	2024-07-05	儿童医学中心公司	新咪唑并嘧啶化合物及其用途
US11730810B2 (en)	2017-11-14	2023-08-22	Children's Medical Center Corporation	Composition comprising an antigen and a substituted imidazo[1,2-a]pyrimidine for enhancing human immune response

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US2785133A (en) *	1954-03-26	1957-03-12	Gen Aniline & Film Corp	Compositions for a method of whitening fine fabrics
KR920702606A (ko)	1989-06-13	1992-10-06	스튜어트 알. 슈터	모노킨(Monokine)의 활성저해
JPH05503919A (ja) *	1989-06-13	1993-06-24	スミスクライン・ビーチャム・コーポレイション	単球および／またはマクロファージによるインターロイキン―１または腫瘍壊死因子生成の抑制
KR930700104A (ko) *	1990-06-12	1993-03-13	원본미기재	5-리프옥시게나제 및 사이클로옥시게나제 경로 개재된 질병의 억제
IL104369A0 (en)	1992-01-13	1993-05-13	Smithkline Beecham Corp	Novel compounds and compositions
GB9303993D0 (en) *	1993-02-26	1993-04-14	Fujisawa Pharmaceutical Co	New heterocyclic derivatives
WO1998007425A1 (en) *	1996-08-21	1998-02-26	Smithkline Beecham Corporation	Imidazole compounds, compositions and use
GB9713726D0 (en) *	1997-06-30	1997-09-03	Ciba Geigy Ag	Organic compounds

2000
- 2000-10-27 MX MXPA01007019A patent/MXPA01007019A/es active IP Right Grant
- 2000-10-27 PT PT00976710T patent/PT1140939E/pt unknown
- 2000-10-27 SK SK989-2001A patent/SK9892001A3/sk unknown
- 2000-10-27 KR KR1020017008715A patent/KR20010089805A/ko not_active Ceased
- 2000-10-27 US US09/698,448 patent/US6610697B1/en not_active Expired - Lifetime
- 2000-10-27 ID IDW00200101720A patent/ID29514A/id unknown
- 2000-10-27 AU AU14445/01A patent/AU784484B2/en not_active Ceased
- 2000-10-27 NZ NZ512957A patent/NZ512957A/en unknown
- 2000-10-27 BR BR0007447-0A patent/BR0007447A/pt not_active IP Right Cessation
- 2000-10-27 RU RU2001122339/04A patent/RU2264403C2/ru not_active IP Right Cessation
- 2000-10-27 CN CNB008045682A patent/CN1255406C/zh not_active Expired - Fee Related
- 2000-10-27 DE DE60018037T patent/DE60018037T2/de not_active Expired - Fee Related
- 2000-10-27 JP JP2001536552A patent/JP2003513977A/ja active Pending
- 2000-10-27 UA UA2001075135A patent/UA70350C2/uk unknown
- 2000-10-27 CA CA002361139A patent/CA2361139A1/en not_active Abandoned
- 2000-10-27 PL PL00348924A patent/PL348924A1/xx not_active IP Right Cessation
- 2000-10-27 HU HU0200207A patent/HUP0200207A3/hu unknown
- 2000-10-27 ES ES00976710T patent/ES2237470T3/es not_active Expired - Lifetime
- 2000-10-27 HK HK02105224.5A patent/HK1043591B/zh not_active IP Right Cessation
- 2000-10-27 WO PCT/US2000/029875 patent/WO2001034605A1/en not_active Ceased
- 2000-10-27 AT AT00976710T patent/ATE288915T1/de not_active IP Right Cessation
- 2000-10-27 CZ CZ20012494A patent/CZ20012494A3/cs unknown
- 2000-10-27 EP EP00976710A patent/EP1140939B1/en not_active Expired - Lifetime
- 2000-11-09 AR ARP000105910A patent/AR026410A1/es not_active Application Discontinuation
2001
- 2001-07-10 NO NO20013419A patent/NO320422B1/no not_active Application Discontinuation
- 2001-07-10 IL IL144238A patent/IL144238A/en not_active IP Right Cessation
- 2001-07-17 BG BG105712A patent/BG65106B1/bg unknown

Also Published As

Publication number	Publication date
BR0007447A (pt)	2002-04-09
WO2001034605A1 (en)	2001-05-17
CN1342162A (zh)	2002-03-27
NO320422B1 (no)	2005-12-05
PT1140939E (pt)	2005-05-31
CZ20012494A3 (cs)	2001-10-17
NO20013419D0 (no)	2001-07-10
ES2237470T3 (es)	2005-08-01
KR20010089805A (ko)	2001-10-08
EP1140939A1 (en)	2001-10-10
HK1043591B (zh)	2006-12-29
US6610697B1 (en)	2003-08-26
IL144238A (en)	2007-03-08
JP2003513977A (ja)	2003-04-15
AR026410A1 (es)	2003-02-12
AU784484B2 (en)	2006-04-13
CA2361139A1 (en)	2001-05-17
HUP0200207A2 (hu)	2002-05-29
DE60018037D1 (de)	2005-03-17
NZ512957A (en)	2005-01-28
PL348924A1 (en)	2002-06-17
SK9892001A3 (en)	2002-04-04
MXPA01007019A (es)	2002-09-18
EP1140939B1 (en)	2005-02-09
CN1255406C (zh)	2006-05-10
DE60018037T2 (de)	2006-01-12
BG65106B1 (bg)	2007-02-28
HUP0200207A3 (en)	2004-07-28
AU1444501A (en)	2001-06-06
HK1043591A1 (en)	2002-09-20
UA70350C2 (en)	2004-10-15
RU2264403C2 (ru)	2005-11-20
BG105712A (en)	2002-06-28
ATE288915T1 (de)	2005-02-15
NO20013419L (no)	2001-08-27

Publication	Publication Date	Title
ID29514A (id)	2001-09-06	2-ARIL-3-(HETEROARIL)-IMIDAZO [1,2-a]PIRIMIDIN TERSUBSTITUSI, DAN METODE-METODE DAN KOMPOSISI-KOMPOSISI FARMASI YANG TERKAIT
IL191960A (en)	2015-11-30	History of imidazo [5,1– a] pyridine and pharmaceutical preparations containing them
HUP0103472A3 (en)	2002-12-28	Pyrrolo[2,3-d]pyrimidine derivatives and pharmaceutical compositions containing the same
DE60005850D1 (de)	2003-11-13	Imidazo[1,2-a]pyridin- und pyrazolo[2,3-a]pyridinderivate
NO20021694D0 (no)	2002-04-10	Pyrazolo[4,3-d]pyrimidinderivater
HUP0303350A3 (en)	2006-02-28	Use of substituted imidazo[1,2-a]pyridine-, imidazo[1,2-a]pyrimidine and imidazo[1,2-a]pyrazine-3-yl-amine derivatives for producing nos-inhibiting pharmaceutical compositions
HUP0400692A3 (en)	2007-09-28	Substituted 7h-pyrrolo[2,3-d]pyrimidine derivatives, their use and pharmaceutical compositions containing them
HUP0402018A3 (en)	2008-06-30	5-amino-7h-pyrazolo[4,3-e][1,2,4]triazolo[1,5-c]pyrimidine derivatives, their use and pharmaceutical compositions containing them
HUP0203503A3 (en)	2004-12-28	Pyrrolo[2,3-d]pirimidine compounds, pharmaceutical compositions containing them and their use
HUP0301114A3 (en)	2004-11-29	Pyrrolo[2,3-d]pyrimidine compounds as immunosuppressive agents and pharmaceutical compositions containing them
IL128869A (en)	2003-09-17	ARYSULFONYL-SUBSTITUTED-PYRAZOLO [1,5-a]-PYRIMIDINE AND PYRAZOLO [1,5-a] [1, 3, 5]-TRIAZINE DERIVATIVES, THEIR PREPARATION AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM
HUP0100179A3 (en)	2002-12-28	Imidazopyrimidine and imidazopyridine derivatives and pharmaceutical compositions thereof
HUP0401047A3 (en)	2007-12-28	Triazolo[4,5-d]pyrimidine derivatives, their use as purinergic receptor antagonist and pharmaceutical compositions containing same
DE69804273D1 (de)	2002-04-25	5h-Thiazolo[3,2-a]pyrimidinderivate
HUP0500332A3 (en)	2009-12-28	Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them
HUP0002902A3 (en)	2002-09-30	3-substituted 3,4 dyhydro-thieno[2,3-d]pyrimidine derivatives and their use for the preparation of pharmaceutical compositions
HUP0500328A3 (en)	2009-12-28	Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5(1h)-one derivatives, their use and pharmaceutical compositions containing them
IL156536A0 (en)	2004-01-04	Pyrazolo [3,4-d] pyrimidin-4-one derivatives and pharmaceutical compositions containing the same
DE60103909D1 (de)	2004-07-22	2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-a]pyrimidin-4-on- und 7-pyridinyl-2,3-dihydroimidazo[1,2-a]pyrimidin-5 1honderivate
HUP0102981A3 (en)	2002-10-28	Pyrrolo[1,2-a]pyrazine derivatives and pharmaceutical compositions thereof
DE50001191D1 (de)	2003-03-06	Pyrazolo[4, 3-d]pyrimidine
EE200100377A (et)	2002-10-15	Imidaso[1,5-a]-pürido[3,2-e]-pürasinoonide kasutamine arstimitena
NO20000605D0 (no)	2000-02-07	3-Substituerte 3,4,5,7-tetrahydro-pyrrolo[3',4':4,5]tieno[2,3- D]pyrimidinderivater, deres fremstilling og anvendelse som 5HT- antagonister
AR025731A1 (es)	2002-12-11	"ditiepino [6,5-b] piridinas benzo-fusionadas y composiciones y metodos relacionados"
PT1326866E (pt)	2005-08-31	3,4-di-hidropirido[1,2-a]pirimidinas substituidas